Lisofylline inhibitor of phospholipid-mediated intracellular signaling: Open label Phase I testing

By WIR Staff | Oct 26, 1998 | 8:00 AM GMT

Cell Therapeutics Inc. (CTIC), Seattle, Wash.
Product: Lisofylline inhibitor of

Read the full 101 word article

How to gain access

Continue reading with a
two-week free trial.